Bernard Arulanandam

Arulanandam Bernard 250

Dr. Bernard Arulanandam is a Professor of Biology and Interim Vice President for Research at the University of Texas at San Antonio. He also is the Scientific Director of the Vaccine Development Center of San Antonio and a founding member of the South Texas Center for Emerging Infectious Diseases. His research focuses on understanding the basic mechanisms of host immune defenses at mucosal sites and has provided new insights into the development of vaccines against Chlamydia trachomatis, the leading global cause of sexually transmitted bacterial disease and to the creation of a potential live attenuated vaccine against multidrug-resistant Acinetobacter baumannii, an important nosocomial pathogen. His research also has led to a better understanding of host-pathogen interactions for vaccine development against the select agent Francisella tularensis and to identification of putative diagnostics biomarkers for this ‘biothreat’ agent. Dr. Arulanandam is a Fellow of the American Association for Advancement of Science.